01 1Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
02 1Wisdom Pharmaceutical Co.,Ltd.
01 2Fluralaner
01 2China
NDC Package Code : 42513-0019
Start Marketing Date : 2023-01-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13612-0023
Start Marketing Date : 2021-05-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
A Fluralaner manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluralaner, including repackagers and relabelers. The FDA regulates Fluralaner manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluralaner API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fluralaner manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fluralaner supplier is an individual or a company that provides Fluralaner active pharmaceutical ingredient (API) or Fluralaner finished formulations upon request. The Fluralaner suppliers may include Fluralaner API manufacturers, exporters, distributors and traders.
click here to find a list of Fluralaner suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fluralaner as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fluralaner API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fluralaner as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fluralaner and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fluralaner NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fluralaner suppliers with NDC on PharmaCompass.
We have 2 companies offering Fluralaner
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
